Mind Cure Health Inc. (MCUR.CN)
Stock analysis · CNQ · Healthcare · Biotechnology
Mind Cure Health Inc. (MCUR.CN) is a publicly traded company in the Healthcare sector. Sign in to Stocks360 for full DCF valuation, fundamentals, technicals, and AI-driven analysis.
Get full analysis → Short-Term Analysis →Proprietary Signals
About Mind Cure Health Inc.
Mind Cure Health Inc. operates as a life sciences firm, dedicated to creating and marketing mental health and wellness solutions across North America. The company's strategy revolves around advancing digital therapeutic technologies and exploring psychedelic compounds, with the goal of rapidly expanding access to scientifically validated, evidence-based mental health treatments. Among its key innovations is iSTRYM, a unique digital therapeutic software application designed to enhance the entire healing journey for patients and clinicians throughout all phases of therapy. It also offers PsyCollage, a bioinformatics platform crucial for guiding research by identifying priority programs. Furthermore, Mind Cure Health produces synthetic ibogaine for distribution to researchers and clinicians, and investigates various psychedelic compounds, particularly ibogaine, for its potential in treating traumatic brain injuries and related conditions. Established in 2020, Mind Cure Health Inc. maintains its headquarters in Vancouver, Canada.
Peers
Recent News
- No recent news available.
Related
Browse more tickers: sitemap